Rizatriptan was developed by Merck & Co. and obtained approval by the Food and Drug Administration (FDA) on June 29th 1998. It represents a second-generation triptan.

Rizatriptan is available only by prescription in the United States and Canada.

Please visit the official site of the FDA for further information.

 

Why is this medication prescribed?

Other uses for this medicine

Dosage and using this medicine

What special precautions should I follow?

What should I do if I forget a dose?

What side effects can this medication cause?

What storage conditions are needed for this medicine?

In case of an emergency/overdose